Compare · head to head
Bora Pharmaceuticals vs Reyon Pharmaceutical
Bora Pharmaceuticals ranks higher overall — 360 rank 27 vs 16.
Bora Pharmaceuticals leads on Quality (56 vs 43) and Growth (47 vs 42). The two are close on Value, Safety and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Taiwan | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Medium | Small |
| ISIN | TW0006472004 | KR7102460003 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 27 | 16 |
| Value | 46 | 44 |
| Quality | 56 | 43 |
| Growth | 47 | 42 |
| Safety | 32 | 33 |
| Sentiment | 44 | 48 |
| Quality details | ||
| Profitability | 55 | 37 |
| Cash Truth | 56 | 50 |
Bora Pharmaceuticals vs BoryungBora Pharmaceuticals vs Kukje PharmaBora Pharmaceuticals vs Kyongbo PharmaceuticalBora Pharmaceuticals vs Hanall BiopharmaAdd a third stock →
Full analyses: Bora Pharmaceuticals · Reyon Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100